Journal of Cancer Education

, Volume 34, Issue 1, pp 98–104 | Cite as

Nurses’ Knowledge and Opinions on HPV Vaccination: a Cross-Sectional Study from Istanbul

  • Ayse Filiz Gokmen KarasuEmail author
  • Ilknur Adanir
  • Serdar Aydin
  • Gulsah Keskin Ilhan
  • Tugba Ofli


Implementing a HPV vaccination program is currently under evaluation by the Turkish health ministry. For screening and vaccination programs to be successful, the cooperation of nurses is essential. We aimed to evaluate (1) basic knowledge of nurses and nursing interns regarding HPV infection and cervical cancer, (2) their attitudes towards smear testing and HPV vaccination, and (3) their viewpoint on vaccination of school age children. This cross-sectional study was undertaken at Bezmialem Vakif University. The survey was designed to assess knowledge about HPV infection, Pap smear testing, cervical cancer, HPV vaccine, attitudes towards HPV vaccination, and school-based vaccination programs. Validity content was determined by expert gynecologists, and a pilot study was performed on 10 nurses. A total of 550 questionnaires were handed out; 499 were completed. Our response rate was 90.7%. Fifty-nine participants answered all the knowledge questions correctly. The calculated knowledge score of the female participants was 6.99 ± 2.22, the male participants was 5.89 ± 2.92. Female participants were more knowledgeable (p < 0.0001). Out of the 353 female participants, 18.6% (n = 66) had undergone smear testing. There were 20 (5.6%) female and 6 (4%) male participants who were vaccinated against HPV. The leading answer for not having a HPV vaccine was “I’m not at risk for a HPV infection” (n = 106, 34.9%). There was a statistical relationship between “HPV knowledge score” and answering “Yes” to “Do you want your children/future children to be vaccinated? (p = 0.001) and “Do you think including the vaccine in the Turkish immunization program is necessary?” (p = 0.001). Nurses in our cohort seem to have satisfactory basic knowledge regarding HPV infection; however, their viewpoints on vaccination were not favorable. Strategies and intervention materials for HPV vaccination will be necessary if a national immunization program will be initiated.


HPV knowledge HPV vaccination HPV infection awareness 



This work was submitted as an abstract to the 12th Congress of the European Society of Gynecology.

Compliance with Ethical Standards

All authors have contributed to the preparation of this paper and have adhered to ethical standards. The study was constructed according to the Declaration of Helsinki and approved by the Institutional Review Board of Bezmialem Vakif University.

Conflict of Interest

The authors declare that they have no conflict of interest.


  1. 1.
    Walboomers JM, Jacobs MV, Manos MM et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12–19CrossRefGoogle Scholar
  2. 2.
    Lowy DR, Schiller JT (2012) Reducing HPV-associated cancer globally. Cancer Prev Res (Phila) 5:18–23CrossRefGoogle Scholar
  3. 3.
    Dalstein V, Riethmuller D, Prétet JL et al (2003) Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer 3:396–403CrossRefGoogle Scholar
  4. 4.
    Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386CrossRefGoogle Scholar
  5. 5.
    de Martel C, Ferlay J, Franceschi S et al (2012) Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 13:607–615CrossRefGoogle Scholar
  6. 6.
    Cates W Jr (1999) Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. Sex Transm Dis 26:S2–S7CrossRefGoogle Scholar
  7. 7.
    Dempsey AF, Abraham LM, Dalton V, Ruffin M (2009) Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus. Ann Epidemiol 19:531–538CrossRefGoogle Scholar
  8. 8.
    Meites E, Kempe A, Markowitz LE (2017) Use of a 2-dose schedule for human papillomavirus caccination—updated recommendations of the Advisory Committee on Immunization Practices. Am J Transplant 17:834–837CrossRefGoogle Scholar
  9. 9.
    Gültekin M, Akgül B (2017) HPV screening in Islamic countries. Lancet Infect Dis 4:368CrossRefGoogle Scholar
  10. 10.
    Genc RE, Sarican ES, Turgay AS et al (2013) Determination of knowledge of Turkish midwifery students about human papilloma virus infection and its vaccines. Asian Pac J Cancer Prev 14:6775–6778CrossRefGoogle Scholar
  11. 11.
    Güvenç G, Akyüz A, Seven M (2012) Determination of the knowledge and attitudes of nursing students about human papilloma virus infection and its vaccines. Gulhane Med J 54:104–110CrossRefGoogle Scholar
  12. 12.
    Bal-Yılmaz H, Koniak-Griffin D (2017) Knowledge, behaviors, and attitudes about human papilloma virus among nursing students in Izmir, Turkey. J Cancer Educ 1:1–7Google Scholar
  13. 13.
    Koc Z, Cinarli T (2015) Cervical cancer, human papillomavirus, and vaccination: knowledge, awareness, and practices among Turkish hospital nurses. Nurs Res 64:452–465CrossRefGoogle Scholar
  14. 14.
    Waller J, McCaffery K, Forrest S et al (2006) Acceptability of unsupervised HPV self-sampling using written instructions. J Med Screen 13:208–213CrossRefGoogle Scholar
  15. 15.
    Goldie SJ, Kohli M, Grima D et al (2004) Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. J Natl Cancer Inst 96:604–615CrossRefGoogle Scholar
  16. 16.
    Kane MA, Sherris J, Coursaget P et al (2006) HPV vaccine use in the developing world. Vaccine 24:S132–S139CrossRefGoogle Scholar
  17. 17.
    Ylitalo KR, Lee H, Mehta NK (2013) Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey. Am J Public Health 103:164–169CrossRefGoogle Scholar
  18. 18.
    Hswen Y, Gilkey MB, Rimer BK et al (2017) Improving physician recommendations for human papillomavirus vaccination: the role of professional organizations. Sex Transm Dis 44:43–48CrossRefGoogle Scholar
  19. 19.
    Jacob M, Bradley J, Barone MA (2005) Human papillomavirus vaccine: what does the future hold for preventing cervical cancer in resource-poor settings through immunization programs? Sex Transm Dis 32:635–640CrossRefGoogle Scholar
  20. 20.
    Wong LP (2009) HPV information needs, educational messages and channel of delivery preferences: views from developing country with multiethnic populations. Vaccine 27:1410–1415CrossRefGoogle Scholar
  21. 21.
    Brewer NT, Fazekas K (2007) Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med 45:107–114CrossRefGoogle Scholar
  22. 22.
    Health Authority Abu Dhabi. HPV vaccine uptake in Abu Dhabi school-based program
  23. 23.
    Sam IC, Wong LP, Rampal S et al (2009) Maternal acceptance of human papillomavirus vaccine in Malaysia. J Adolesc Health 44:610–612CrossRefGoogle Scholar
  24. 24.
    Cochi SL, Freeman A, Guirguis S, Jafari H, Aylward B (2014) Global polio eradication initiative: lessons learned and legacy. J Infect Dis 210(suppl 1):S540–S546CrossRefGoogle Scholar
  25. 25.
    Orenstein WA, Strebel PM, Papania M, Sutter RW, Bellini WJ, Cochi SL (2000) Measles eradication: is it in our future? Am J Public Health 90:1521–1525CrossRefGoogle Scholar

Copyright information

© American Association for Cancer Education 2017

Authors and Affiliations

  1. 1.Faculty of Medicine, Department of Obstetrics and GynecologyBezmialem Vakif UniversityİstanbulTurkey
  2. 2.Department of Obstetrics and GynecologySuleymaniye Maternity Training and Research HospitalIstanbulTurkey

Personalised recommendations